JAMA Otolaryngol Head Neck Surg:单侧耳聋儿童的耳蜗植入治疗

2020-11-16 AlexYang MedSci原创

最近,有研究人员评估了因单侧耳聋(SSD)而接受人工耳蜗植入的儿童的听觉和患者报告的结果情况,并评估了植入时间、主观结果和人工耳蜗装置使用率之间的关系。

最近,有研究人员评估了因单侧耳聋(SSD)而接受人工耳蜗植入的儿童的听觉和患者报告的结果情况,并评估了植入时间、主观结果和人工耳蜗装置使用率之间的关系。

研究包括了12项观察性研究,共评估了119名接受人工耳蜗植入的SSD儿童(平均[SD]年龄:6.6[4.0]岁)。结果表明,大多数儿童在噪音(49名儿童中的39名[79.6%])和安静(42名儿童中的34名[81.0%])中的语言感知具有临床意义的改善。长时间的耳聋(先天性SSD时间超过4年,语前SSD时间超过7年)是最常见的没有改善原因。人工耳蜗植入后,通过与真实位置的误差度测量的声音定位(平均差值[MD],-24.78°;95%CI,-34.16°至-15.40°;I2 = 10%)在统计学上有显著改善。与先天性SSD患者相比,后天性SSD患者和耳聋持续时间较短的患者在言语(MD,2.27;95%CI,1.89-2.65 vs 1.58;95%CI,1.00-2.16)和空间(MD,2.95;95%CI,2.66-3.24 vs 1.68;95%CI,0.96-2.39)听力质量上有较大改善。另外,设备非使用者的耳聋持续时间显著长于普通设备使用者的耳聋持续时间(中位数差异,6.84;95%CI,4.02-9.58)。

最后,研究人员指出,他们的系统性回顾和荟萃分析发现,SSD儿童的人工耳蜗植入与听觉和患者报告的结果有临床意义的改善相关;较短的耳聋持续时间可能会带来更好的植入结果。他们的这些发现可以指导未来的研究工作,完善人工耳蜗植入候选标准,并能够协助家庭咨询和共同决策。

原始出处:

Liliya Benchetrit, Evette A Ronner, Samantha Anne et al. Cochlear Implantation in Children With Single-Sided Deafness: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. Nov 2020

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076765, encodeId=965520e676546, content=<a href='/topic/show?id=9f6e62685fe' target=_blank style='color:#2F92EE;'>#植入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62685, encryptionId=9f6e62685fe, topicName=植入治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Apr 14 06:22:15 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044166, encodeId=539f2044166fd, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 08 03:22:15 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520712, encodeId=14b61520e1275, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533322, encodeId=f68615333228c, content=<a href='/topic/show?id=489b8051402' target=_blank style='color:#2F92EE;'>#耳蜗植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80514, encryptionId=489b8051402, topicName=耳蜗植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948e12427215, createdName=119337461, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036346, encodeId=4d721036346b2, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Nov 16 17:22:15 CST 2020, time=2020-11-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2076765, encodeId=965520e676546, content=<a href='/topic/show?id=9f6e62685fe' target=_blank style='color:#2F92EE;'>#植入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62685, encryptionId=9f6e62685fe, topicName=植入治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Apr 14 06:22:15 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044166, encodeId=539f2044166fd, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 08 03:22:15 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520712, encodeId=14b61520e1275, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533322, encodeId=f68615333228c, content=<a href='/topic/show?id=489b8051402' target=_blank style='color:#2F92EE;'>#耳蜗植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80514, encryptionId=489b8051402, topicName=耳蜗植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948e12427215, createdName=119337461, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036346, encodeId=4d721036346b2, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Nov 16 17:22:15 CST 2020, time=2020-11-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2076765, encodeId=965520e676546, content=<a href='/topic/show?id=9f6e62685fe' target=_blank style='color:#2F92EE;'>#植入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62685, encryptionId=9f6e62685fe, topicName=植入治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Apr 14 06:22:15 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044166, encodeId=539f2044166fd, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 08 03:22:15 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520712, encodeId=14b61520e1275, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533322, encodeId=f68615333228c, content=<a href='/topic/show?id=489b8051402' target=_blank style='color:#2F92EE;'>#耳蜗植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80514, encryptionId=489b8051402, topicName=耳蜗植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948e12427215, createdName=119337461, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036346, encodeId=4d721036346b2, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Nov 16 17:22:15 CST 2020, time=2020-11-16, status=1, ipAttribution=)]
    2020-11-18 jiyangfei
  4. [GetPortalCommentsPageByObjectIdResponse(id=2076765, encodeId=965520e676546, content=<a href='/topic/show?id=9f6e62685fe' target=_blank style='color:#2F92EE;'>#植入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62685, encryptionId=9f6e62685fe, topicName=植入治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Apr 14 06:22:15 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044166, encodeId=539f2044166fd, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 08 03:22:15 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520712, encodeId=14b61520e1275, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533322, encodeId=f68615333228c, content=<a href='/topic/show?id=489b8051402' target=_blank style='color:#2F92EE;'>#耳蜗植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80514, encryptionId=489b8051402, topicName=耳蜗植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948e12427215, createdName=119337461, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036346, encodeId=4d721036346b2, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Nov 16 17:22:15 CST 2020, time=2020-11-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2076765, encodeId=965520e676546, content=<a href='/topic/show?id=9f6e62685fe' target=_blank style='color:#2F92EE;'>#植入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62685, encryptionId=9f6e62685fe, topicName=植入治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Apr 14 06:22:15 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044166, encodeId=539f2044166fd, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 08 03:22:15 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520712, encodeId=14b61520e1275, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533322, encodeId=f68615333228c, content=<a href='/topic/show?id=489b8051402' target=_blank style='color:#2F92EE;'>#耳蜗植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80514, encryptionId=489b8051402, topicName=耳蜗植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=948e12427215, createdName=119337461, createdTime=Wed Nov 18 05:22:15 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036346, encodeId=4d721036346b2, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Nov 16 17:22:15 CST 2020, time=2020-11-16, status=1, ipAttribution=)]
    2020-11-16 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

Int Arch Otorhinolaryngol:耳蜗植入前评估:重度双侧舌前听力损失儿童的临床资料和家族史

巴基斯坦的耳聋患病率高。对深度听力损失患者的临床特征的了解不仅有助于查明原因,也有助于公共卫生干预措施的策略规划。

感染新冠死亡风险5-9岁儿童很低 每增加5岁增0.59%

国际著名学术期刊《自然》最新发表一项新的流行病学模型研究论文称,在新冠病毒(SARS-CoV-2)感染导致死亡风险方面,65岁以下人群按年龄划分在各国一致;5-9岁儿童的感染相关死亡风险最低,年龄每增

JCEM:儿童毛发皮质醇浓度与脂肪的关系

6岁时较高的HCC与10岁时BMI、FMI、肝脂肪分数升高以及较高的超重和NAFLD风险有关,仅肝脂肪分数和NAFLD的关联独立于6岁时FMI。

赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作

Dupixent是是唯一一个在III期临床试验中显著改善儿童肺功能的生物制剂。

Eur Arch Otorhinolaryngol:耳蜗植入儿童的社会能力:有可能赶上他们的同龄人么?

最近,有研究人员比较了CI患儿和听力正常的同龄人的社会能力技能情况。

Pediatr Res:糠酸氟替卡松在小儿过敏性鼻炎中的应用:随机对照研究

鼻内皮质类固醇是治疗过敏性鼻炎(AR)最有效的抗炎药。然而在中国国内尚未对儿童鼻内皮质激素的疗效和安全性进行专门研究。最近,有研究人员调查了糠酸氟替卡松鼻腔喷雾剂(FFNS)在中国儿童人群中的疗效和安